Pre-eclampsia primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Pre-eclampsia}} | {{Pre-eclampsia}} | ||
{{CMG}}; {{AE}} {{Sara.Zand}} | {{CMG}}; {{AE}} {{Sara.Zand}} | ||
== Primary prevention == | |||
*Effective measures for the primary prevention of [[preeclampsia ]] include administration of low dose [[aspirin]] before the 16th week of [[pregnancy]]. | *Effective measures for the primary prevention of [[preeclampsia ]] include administration of low dose [[aspirin]] before the 16th week of [[pregnancy]]. | ||
Revision as of 10:59, 7 October 2020
|
Pre-eclampsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pre-eclampsia primary prevention On the Web |
|
American Roentgen Ray Society Images of Pre-eclampsia primary prevention |
|
Risk calculators and risk factors for Pre-eclampsia primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Primary prevention
- Effective measures for the primary prevention of preeclampsia include administration of low dose aspirin before the 16th week of pregnancy.
- In a recent clinical trial, there was 62% reduction in the occurrence of preeclampsia in patients received 150 mg aspirin daily.